Capital Counsel’s Colgate-Palmolive CL Stock Holding History

Capital Counsel’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-18,687	Closed	-$1.25M	–	76
2015 Q4	$1.25M	Hold	18,687	–	–	0.07%	51
2015 Q3	$1.19M	Buy	18,687 +58	+0.3%	+$3.79K	0.06%	51
2015 Q2	$1.22M	Hold	18,629	–	–	0.06%	52
2015 Q1	$1.29M	Buy	18,629 +399	+2%	+$27.6K	0.06%	52
2014 Q4	$1.26M	Hold	18,230	–	–	0.06%	55
2014 Q3	$1.19M	Sell	18,230 -5	-0%	-$330	0.07%	52
2014 Q2	$1.24M	Sell	18,235 -100	-0.5%	-$6.7K	0.07%	50
2014 Q1	$1.19M	Hold	18,335	–	–	0.06%	51
2013 Q4	$1.2M	Hold	18,335	–	–	0.07%	52
2013 Q3	$1.09M	Buy	18,335 +135	+0.7%	+$8K	0.06%	51
2013 Q2	$1.04M	Buy	+18,200	New	+$1.08M	0.06%	51

Other funds holding CL

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital Counsel's CL Position: Q1 2016 in Review

Capital Counsel sold out of Colgate-Palmolive (CL) in Q1 2016, closing a stake of 18,687 shares — an estimated $1.25M sold.

Capital Counsel first reported a position in CL in Q2 2013 and held it in 11 quarters. The position peaked at $1.29M in Q1 2015. 1,263 funds tracked by Wall St. Rank hold CL as of Q1 2016.

Capital Counsel reported no remaining Colgate-Palmolive position as of Q1 2016 after selling out during the quarter.
Capital Counsel sold 18,687 Colgate-Palmolive shares in Q1 2016, an estimated $1.25M.
Capital Counsel first reported a position in Colgate-Palmolive in Q2 2013 and held it in 11 quarters.
Capital Counsel's Colgate-Palmolive position peaked at $1.29M in Q1 2015.
1,263 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2016.

Based on Capital Counsel's 13F filing for Q1 2016, filed 13 May 2016.